Trials / Recruiting
RecruitingNCT06416969
Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
Stimulation of Regional Lipolysis and Adipocyte Lipolysis Proteins
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to factors that "turn on" fat cells the same way as people who don't have excessive weight. Researchers are trying to understand why fat tissue responds differently in people with different body types.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatostatin | Intravenous infusion 200 ug/hr for 2 hours, 100 ug/hr for 30 minutes |
| DRUG | Epinephrine | Intravenous infusion |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2024-05-16
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06416969. Inclusion in this directory is not an endorsement.